Tumor necrosis factor alpha differentially regulates beta-endorphin concentrations and proopiomelanocortin RNA in the anterior and neurointermediate pituitary in vivo

Neuroimmunomodulation. 1994 Nov-Dec;1(6):357-60. doi: 10.1159/000097188.

Abstract

We analyzed the effect of tumor necrosis factor alpha (TNF-alpha) on beta-endorphin concentrations and proopiomelanocortin mRNA in the rat anterior and neurointermediate pituitaries. The intraperitoneal injection of 5 micrograms/kg TNF-alpha decreases beta-endorphin in neurointermediate pituicytes 4, 8 and 24 h after the treatment without affecting proopiomelanocortin (POMC) RNA. In contrast, in the anterior pituitary 4 h after the injection of the cytokine, POMC RNA was decreased while the peptide content was increased. These effects can be relevant to the modulation of the pituitary-adrenal axis and immune responses in conditions, such as infections, in which TNF levels are increased.

MeSH terms

  • Animals
  • Gene Expression Regulation / drug effects*
  • Injections, Intraperitoneal
  • Male
  • Pituitary Gland / drug effects*
  • Pituitary Gland / metabolism
  • Pituitary Gland, Anterior / drug effects
  • Pituitary Gland, Anterior / metabolism
  • Pro-Opiomelanocortin / biosynthesis*
  • Pro-Opiomelanocortin / genetics
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Rats
  • Rats, Inbred Lew
  • Recombinant Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / pharmacology*
  • beta-Endorphin / biosynthesis*
  • beta-Endorphin / genetics

Substances

  • RNA, Messenger
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • beta-Endorphin
  • Pro-Opiomelanocortin